Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

China flag China · Delayed Price · Currency is CNY
11.71
-0.08 (-0.68%)
Mar 11, 2026, 10:54 AM CST
46.56%
Market Cap 3.75B
Revenue (ttm) 790.86M
Net Income (ttm) 226.35M
Shares Out 317.69M
EPS (ttm) 0.70
PE Ratio 16.82
Forward PE n/a
Dividend 0.25 (2.17%)
Ex-Dividend Date Jun 18, 2025
Volume 2,364,300
Average Volume 4,154,093
Open 11.81
Previous Close 11.79
Day's Range 11.65 - 11.81
52-Week Range 7.21 - 16.97
Beta 0.22
RSI 55.31
Earnings Date Apr 24, 2026

About SHA:603811

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 1966
Employees 637
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603811
Full Company Profile

Financial Performance

In 2024, SHA:603811's revenue was 714.37 million, an increase of 6.36% compared to the previous year's 671.63 million. Earnings were 200.70 million, an increase of 23.21%.

Financial Statements

News

There is no news available yet.